$1.48
-0.04 (-2.63%)
Open$1.31
Previous Close$1.52
Day High$1.48
Day Low$1.17
52W High$71.50
52W Low$1.07
Volume—
Avg Volume31.1K
Market Cap2.47M
P/E Ratio—
EPS$-25.56
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+535.1% upside
Current
$1.48
$1.48
Target
$9.40
$9.40
$5.45
$9.40 avg
$11.97
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.76M | 2.16M | 1.98M |
| Net Income | -82,156,197 | -609,365 | -497,914 |
| Profit Margin | -2,980.4% | -28.2% | -25.1% |
| EBITDA | -81,785,350 | -937,252 | -843,277 |
| Free Cash Flow | — | -606,690 | -515,846 |
| Rev Growth | +100.0% | +2.0% | +14.6% |
| Debt/Equity | — | 0.62 | 0.60 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |